logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Vladimir Genukh Beylin

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent. Top assignees: Warner-Lambert Company, British Tech. Group, British Technology Group Limited. Active years: 1987-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Genukh Beylin. Retrieved from https://idiyas.com/inventor/vladimir-genukh-beylin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 84.6

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 64(Granted Patents)


Company Filing History:

goldMedal12 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal1 out of 1 
 
British Tech. Group
 patent
bronzeMedal1 out of 328 
 
British Technology Group Limited
 patents
4. 1 out of 4,488 
 
Pfizer Corporation
 patents
where one patent can have more than one assignee

Years Active: 1987-2011

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 7863278 - Isethionate salt of a selective CDK4 inhibitor (2011-01-04),
2. 7655656 - Hair growth promoting agents (2010-02-02),
3. 6960662 - Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones (2005-11-01),
4. 5659048 - Chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and (1997-08-19),
5. 5481000 - Process for preparing chiral (1996-01-02),
6. 5449778 - Cyclic amino acids and derivatives thereof (1995-09-12),
7. 5380925 - Cyclic amino acids and derivatives thereof (1995-01-10),
8. 5342959 - Process for preparing chiral (1994-08-30),
9. 5264577 - Cyclic amino acids and derivatives thereof (1993-11-23),
10. 5198548 - Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and (1993-03-30),
11. 4806654 - Processes for the preparation of benzo(chalcogeno)(4,3,2-cd)indazoles (1989-02-21),
12. 4689423 - Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates (1987-08-25),
13. 4672129 - Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones (1987-06-09),

Title: Vladimir Genukh Beylin: Innovator in Pharmaceutical Patents

Introduction

Vladimir Genukh Beylin is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on developing innovative compounds that address critical health issues.

Latest Patents

Among his latest patents is the isethionate salt of a selective CDK4 inhibitor. This invention discloses polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which serves as a selective cyclin-dependent kinase 4 (CDK4) inhibitor. This compound is particularly useful for treating inflammation and cell proliferative diseases such as cancer and restenosis. Another notable patent involves hair growth promoting agents, which are directed to crystalline forms of 6-[[[3S,4R)-3,4-dihydro-3-hydroxy-6-[(3-hydroxypheny)sulfonyl]-2,2,3-trimethyl-2H-1-benzopyran-4-yl]oxy]-2-methyl-3(2H)-pyridazinone. This invention includes formulations containing these crystalline forms and their application in promoting hair growth.

Career Highlights

Vladimir has worked with several notable companies throughout his career, including Warner-Lambert Company and British Tech Group. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Vladimir has collaborated with esteemed colleagues such as Om Prakash Goel and Huai G Chen. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Vladimir Genukh Beylin is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in health-related innovations. His contributions through various patents demonstrate his commitment to improving medical treatments and addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…